FDA.reportPublic FDA data

Tyvaso DPI 16-32-48 MCG Titration Pack

RxCUI
2602770
RxNorm name
Tyvaso DPI 16-32-48 MCG Titration Pack
Display name
Tyvaso DPI 16-32-48 MCG Titration Pack
Full name
Tyvaso DPI 16-32-48 MCG Titration Pack
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ddc3d400-bcb3-4b09-aae2-0768b10a5b0fTyvaso DPI 16-32-48 MCG Titration PackPSN14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0f{112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 28 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-32-48 MCG Titration Pack]BPCK14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120
ddc3d400-bcb3-4b09-aae2-0768b10a5b0fTyvaso DPI 16-32-48 MCG Titration PackSY14These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI ® (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 200220251120